Wave Life Sciences (WVE) Total Current Liabilities (2014 - 2026)
Wave Life Sciences posted quarterly Total Current Liabilities of $49.8 million for Q1 2026, down 42.96% year-on-year from $87.4 million in Q1 2025, and down 47.58% on a QoQ basis from $95.1 million in Q4 2025.
Wave Life Sciences (WVE) has 13 years of Total Current Liabilities data on file, last reported at $49.8 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities fell 42.96% year-over-year to $49.8 million; the trailing twelve-month figure through Mar 2026 stood at $49.8 million (down 42.96% YoY), and the FY2025 full-year result was $95.1 million, down 14.32% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $49.8 million, down from $95.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $186.4 million in Q4 2023 and bottomed at $49.8 million in Q1 2026.
- The 5-year median for Total Current Liabilities is $95.1 million (2025), against an average of $108.5 million.
- The widest annual swing landed in 2023, when Total Current Liabilities jumped 160.68%; it then plunged 49.69% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $71.5 million in 2022, then soared by 160.68% to $186.4 million in 2023, then tumbled by 40.49% to $111.0 million in 2024, then dropped by 14.32% to $95.1 million in 2025, then tumbled by 47.58% to $49.8 million in 2026.
- The last three Total Current Liabilities figures came in at $49.8 million (Q1 2026), $95.1 million (Q4 2025), and $85.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - | 49.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.83 Mn |
| Dec 31, 2025 | 95.07 Mn |
| Sep 30, 2025 | 85.90 Mn |
| Jun 30, 2025 | 87.41 Mn |
| Mar 31, 2025 | 87.37 Mn |
| Dec 31, 2024 | 110.95 Mn |
| Sep 30, 2024 | 170.73 Mn |
| Jun 30, 2024 | 173.13 Mn |
| Mar 31, 2024 | 165.87 Mn |
| Dec 31, 2023 | 186.44 Mn |
| Sep 30, 2023 | 99.98 Mn |
| Jun 30, 2023 | 140.23 Mn |
| Mar 31, 2023 | 132.57 Mn |
| Dec 31, 2022 | 71.52 Mn |
| Sep 30, 2022 | 64.26 Mn |
| Jun 30, 2022 | 64.08 Mn |
| Mar 31, 2022 | 58.49 Mn |
| Dec 31, 2021 | 64.20 Mn |
| Sep 30, 2021 | 31.64 Mn |
| Jun 30, 2021 | 46.72 Mn |
| Mar 31, 2021 | 48.68 Mn |
| Dec 31, 2020 | 121.04 Mn |
| Sep 30, 2020 | 109.66 Mn |
| Jun 30, 2020 | 110.45 Mn |
| Mar 31, 2020 | 118.88 Mn |
| Dec 31, 2019 | 118.15 Mn |
| Sep 30, 2019 | 133.41 Mn |
| Jun 30, 2019 | 124.08 Mn |
| Mar 31, 2019 | 131.88 Mn |
| Dec 31, 2018 | 130.04 Mn |
| Sep 30, 2018 | 125.80 Mn |
| Jun 30, 2018 | 43.78 Mn |
| Mar 31, 2018 | 16.30 Mn |
| Dec 31, 2017 | 18.19 Mn |
| Sep 30, 2017 | 15.12 Mn |
| Jun 30, 2017 | 15.56 Mn |
| Mar 31, 2017 | 14.07 Mn |
| Dec 31, 2016 | 12.16 Mn |
| Sep 30, 2016 | 11.43 Mn |
| Jun 30, 2016 | 8.65 Mn |
| Mar 31, 2016 | 3.77 Mn |
| Dec 31, 2015 | 3.82 Mn |
| Sep 30, 2015 | 3.47 Mn |
| Dec 31, 2014 | 882,000.00 |